跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-191
首页
药物
R-191
R-191
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
申请人: UCB SA
优先权: 2001
US
2 件公开
Alkylammonium salts of omepazole and esomeprazole
申请人: DAHLSTROM MIKAEL
优先权: 2004
US
BENZO[A]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME
申请人: CANON KK
优先权: 2007
WO
Use of hydroxyoleic acid and related compounds as functional food additives
申请人: ESCRIBA RUIZ PABLO V
优先权: 2003
US
Piperidine derivatives useful for treating osteoarthritis and osteoartrosis
申请人: ASTRAZENECA AB
优先权: 2006
CN
3-Substituted-4-pyrimidone derivatives
申请人: SANOFI AVENTIS OF PARIS FRANCE
优先权: 2002
US
Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
申请人: KAMENECKA THEODORE M
优先权: 2006
US
Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells
申请人: TEASLEY MARK F
优先权: 2005
US
药物
反馈